ANI Pharmaceuticals, Inc. (ANIP)
73.29
-0.22
(-0.30%)
USD |
NASDAQ |
Aug 28, 13:00
ANI Pharmaceuticals Cash from Operations (Quarterly) : 56.67M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.67M |
| March 31, 2026 | 58.38M |
| December 31, 2025 | 30.37M |
| September 30, 2025 | 44.06M |
| June 30, 2025 | 75.81M |
| March 31, 2025 | 34.99M |
| December 31, 2024 | 15.86M |
| September 30, 2024 | 12.47M |
| June 30, 2024 | 17.41M |
| March 31, 2024 | 18.27M |
| December 31, 2023 | 44.74M |
| September 30, 2023 | 32.17M |
| June 30, 2023 | 20.63M |
| March 31, 2023 | 21.42M |
| December 31, 2022 | -4.40M |
| September 30, 2022 | 3.623M |
| June 30, 2022 | -11.48M |
| March 31, 2022 | -18.94M |
| December 31, 2021 | -12.18M |
| September 30, 2021 | -5.402M |
| June 30, 2021 | 0.241M |
| March 31, 2021 | 20.67M |
| December 31, 2020 | -5.709M |
| September 30, 2020 | -1.614M |
| June 30, 2020 | 20.88M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.71M |
| December 31, 2019 | 4.803M |
| September 30, 2019 | 21.79M |
| June 30, 2019 | 4.744M |
| March 31, 2019 | 14.29M |
| December 31, 2018 | 25.81M |
| September 30, 2018 | 8.166M |
| June 30, 2018 | 8.593M |
| March 31, 2018 | 22.93M |
| December 31, 2017 | 15.80M |
| September 30, 2017 | 17.08M |
| June 30, 2017 | 0.001M |
| March 31, 2017 | 6.529M |
| December 31, 2016 | 12.38M |
| September 30, 2016 | 1.084M |
| June 30, 2016 | 3.043M |
| March 31, 2016 | 10.97M |
| December 31, 2015 | 4.702M |
| September 30, 2015 | 10.24M |
| June 30, 2015 | 1.206M |
| March 31, 2015 | 1.12M |
| December 31, 2014 | 10.74M |
| September 30, 2014 | 4.159M |
| June 30, 2014 | 1.954M |
| March 31, 2014 | 5.179M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Viatris, Inc. | 381.80M |
| Liquidia Corp. | 80.24M |
| Elanco Animal Health, Inc. | 277.00M |
| Harmony Biosciences Holdings, Inc. | 92.43M |
| Corcept Therapeutics, Inc. | 33.54M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -3.054M |
| Cash from Financing (Quarterly) | -4.647M |
| Free Cash Flow | 167.52M |
| Free Cash Flow Per Share (Quarterly) | 2.446 |
| Free Cash Flow to Equity (Quarterly) | 56.88M |
| Free Cash Flow to Firm (Quarterly) | 58.61M |
| Free Cash Flow Yield | 10.59% |